Mesna Injection

[05 February 2016]

Products Affected - Description

Mesna solution for injection, Mylan Institutional
100 mg/mL, 10 mL vial, 10 count (NDC 67457-0148-10)

Reason for the Shortage

  • Fresenius Kabi had mesna on shortage due to increased demand.
  • Mylan could not give a reason for the shortage of mesna.
  • Sagent had mesna on shortage due to manufacturing delays.
  • Teva had a shortage of mesna injection due to manufacturing delays.
  • West-Ward discontinued mesna injection in September 2014.

Available Products

Mesnex solution for injection, Baxter
100 mg/mL, 10 mL vial, 1 count (NDC 00338-1305-01)
100 mg/mL, 10 mL vial, 10 count (NDC 00338-1305-03)
Mesna injection, Baxter
100 mg/mL, 10 mL vial, 1 count (NDC 10019-0953-01)
100 mg/mL, 10 mL vial, 10 count (NDC 10019-0953-02)
Mesna solution for injection, Fresenius Kabi
100 mg/mL, 10 mL vial, 1 count (NDC 63323-0733-11)
100 mg/mL, 10 mL vial, 10 count (NDC 63323-0733-10) 
Mesna injection, Sagent
100 mg/mL, 10 mL vials, 1 count (NDC 25021-0201-10)
100 mg/mL, 10 mL vial, 10 count (NDC 25021-0201-11)
Mesna injection, Teva
100 mg/mL, 10 mL vial, 10 count (NDC 00703-4805-03)

Estimated Resupply Dates

  • Mylan Institutional has mesna 10 mL vials on back order and the company cannot estimate a release date.
  • All other marketed suppliers have product available.

Related Shortages


February 5, 2016; December 9, October 29, September 3, August 13, July 8, May 18, April 9, March 13, February 23, 18 and 2, January 16 and 9, 2015; December 12, 2014, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing